2009 Fiscal Year Final Research Report
The evaluation of Midkine as a therapeutic target in neuroblastoma model mice and the further search for other targets
Project/Area Number |
20790251
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Pathological medical chemistry
|
Research Institution | Nagoya University |
Principal Investigator |
SATOSHI Kishida Nagoya University, 大学院・医学系研究科, 助教 (20402563)
|
Project Period (FY) |
2008 – 2009
|
Keywords | 神経芽腫 / モデルマウス / ミッドカイン / 分子標的治療 |
Research Abstract |
We evaluated the novel therapeutic target of neuroblastoma, a pediatric solid tumor, in model mice. We showed that Midkine, the gene we identified before, was involved in the tumorigenesis of neuroblastoma, and could be an effective target for molecular therapy. On the other hand, we searched the other genes involved in neuroblastoma by comprehensive expression analysis, and identified some potent candidates.
|
-
[Journal Article] Transforming growth factor-b1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury2009
Author(s)
Yin, J., Sakamoto, K., Zhang, H., Ito, Z., Imagama, S., Kishida, S., Natori, T., Sawada, M., Matsuyama, Y., Kadomatsu, K.
-
Journal Title
Brain Res., refereed 1263
Pages: 10-22
-
[Journal Article] Plasma midkine level is a prognostic factor for human neuroblastoma.2008
Author(s)
Ikematsu, S., Nakagawara, A., Nakamura, Y., Ohira, M., Shinjo, M., Kishida, S., Kadomatsu, K.
-
Journal Title
Cancer Sci., refereed 99
Pages: 2070-2074
-
-
-
-
-